|
[Contact]
[CV] [Publications]
Overview
My
research program is focused on quantitative studies of immune cell
and system function with the aim of developing a predictive
mechanistic understanding that will lead to new strategies to
prevent, diagnose, and treat disease. We use modern
biochemical and cell biological tools complemented by an active
technology development component that includes reagents, assays, and
instrumentation to enable quantitative analysis of key biological
features. Our current work involves the development of new methods
for high throughput screening and highly multiplexed analysis,
quantitative analysis of the antibody response, and interactions
between the immune and hemostasis systems, all in the context of
intervening in the interactions between mammalian hosts and
microbial pathogens.
High
Throughput Screening and Multiplexed Molecular Analysis
|
A
key need for modern biology research is to make many quantitative
molecular measurements on very small samples. Our lab has been
a leader in the development of multiplex assay technology that
employs optically encoded microspheres and flow cytometry to make
quantitative and sensitive molecular measurements. We have developed
these approaches in the course of studies on the mechanisms of DNA
repair, interactions between bacterial toxins and their receptors,
susceptibility to virus induced cancer, and the detection of
microbial pathogens.
|
Generic
Approach to Molecular Analysis Using
Microspheres in Solid Supports

|
|
|
One
current project, funded via an NIH Bioengineering Research
Partnership, aims to develop a new platform for high throughput
screening and highly multiplexed analysis based on Raman Flow
Cytometry. This effort is targeted at developing diagnostics and
therapeutics for microbial pathogens. As part of this project, we
recently developed a rapid multiplexed approach to the screening of
phage-display libraries. Other efforts are focused on quantitative
molecular analysis of the immune and coagulation systems, as
described below.
|
Raman
spectra measured in flow. |
|
Quantitative
Analysis of the Antibody Response
|
The
production of an effective antibody response depends on the
production of enough antibodies with sufficient affinity to
neutralize a pathogen. Effectiveness is often determined empirically
in the form of protection, but it is desirable to understand
protection in quantities terms of antigen-specific affinity. Popular
titer-based methods of assessing antigen specific immune responses
do not discern between antibody concentration and affinity, a
critical distinction. We have developed an assay and analysis formalism that is
able to measure both concentration and affinity across multiple
isotypes simultaneously. Combined with our high throughput analysis
capabilities, this approach has the potential to revolutionize our
understanding of the development of the immune response, leading to
a more complete understanding of the evolution of the antibody
response and improved approaches for vaccine development.
|

 
|
|
Analysis
of antigen-specific antibodies:
Titer
vs affinity |
Crosstalk
between the Immune and Hemostasis Systems
|
The
interaction between inflammation and coagulation in many
diseases is well established, but molecular mechanisms and
practical treatment strategies have been slow to emerge.
Multiple lines of evidence implicate cell-derived membrane
vesicles as key mediators of this interaction, but these
very small (100 nm) circulating molecular assemblies are
exceedingly difficult to study. We are developing
instrumentation, including a Microparticle Flow
Cytometer, and associated methods to enable the
quantitative enumeration and analysis of cell-derived
microparticles, with the aim of developing mechanism-based
biomarkers of disease. These efforts aim to open
a new window on plasma components that mediated
interaction between the immune and hemostasis systems. |

A
Microparticle Flow Cytometer |
Representative
Publications
Deshpande,A.,
J.P.Nolan, P.S.White, Y.E.Valdez, W.C.Hunt, C.L.Peyton, and
C.M.Wheeler. 2005. TNF-alpha promoter polymorphisms and
susceptibility to human papillomavirus 16-associated cervical
cancer. J Infect. Dis. 191:969-976.
Yan,X.,
W.Zhong, A.Tang, E.G.Schielke, W.Hang, and J.P.Nolan. 2005.
Multiplexed flow cytometric immunoassay for influenza virus
detection and differentiation. Anal. Chem. 77:7673-7678.
Graves,S.W.,
T.A.Woods, H.Kim, and J.P.Nolan. 2005. Direct fluorescent staining
and analysis of proteins on microspheres using CBQCA. Cytometry A
65:50-58.
Nolan,J.P.
and F.Mandy. 2006. Multiplexed and microparticle-based analyses:
quantitative tools for the large-scale analysis of biological
systems. Cytometry A 69:318-325.
van
der Heyde,H.C., J.Nolan, V.Combes, I.Gramaglia, and G.E.Grau. 2006.
A unified hypothesis for the genesis of cerebral malaria:
sequestration, inflammation and hemostasis leading to
microcirculatory dysfunction. Trends in Parasitology 22:503-508.
Goddard,G.,
J.C.Martin, M.Naivar, P.M.Goodwin, S.W.Graves, R.Habbersett,
J.P.Nolan, and J.H.Jett. 2006. Single particle high resolution
spectral analysis flow cytometry. Cytometry A 69:842-851.
van
der Heyde,H.C., J.M.Burns, W.P.Weidanz, J.Horn, I.Gramaglia, and
J.P.Nolan. 2007. Analysis of antigen-specific antibodies and their
isotypes in experimental malaria. Cytometry A 71:242-250.
[top]
|